Vectalys Private

Vectalys is a private biotech company founded in 2005 by Pascale Bouillé. With a team of 25 employees, Vectalys specializes in gene delivery using lentiviral vectors. Their goal is to help scientists worldwide understand cellular and molecular mechanisms to discover new drugs and therapies. Vectalys has developed a proprietary technology that provides high-quality lentiviral vectors for transducing hard-to-transfect cells, ensuring 100% transduction efficiency and non-toxic transduction. They also offer custom lentiviral vectors and ready-to-use lentiviral vectors with fluorescent, bioluminescent, or gene editing proteins, which are distributed globally. Vectalys is dedicated to providing solutions that save time and support ambitious research projects.

Investors

Technology: Regenerative Medicine
Headquarters: Toulouse, Midi-Pyrenees, France
Funding Status: M&A
Founded Date: 2005-01-01
Last Funding Type: Venture - Series Unknown
Investors Number: 5
Estimated Revenue: $1M to $10M
Employee Number: Nov-50
Total Funding: €4.8M
Industry: Stem Cells (Regenerative Medicine)
Investor Type: For Profit
Register and Claim Ownership